F071 Immunolocalization of high-density lipoproteins in arterial walls of rats

1998 ◽  
Vol 136 ◽  
pp. S64
Author(s):  
Vie Cheng Yang ◽  
Wei-Ting Chou ◽  
Tong-Young Lee ◽  
Chen-Heng Kao
Keyword(s):  
High Density ◽  
High Density Lipoproteins ◽  
Arterial Walls

Long-Term Low-Dose Treatment With Reserpine of Cholesterol-Fed Rabbits Reduces Cholesterol in Plasma, Non-High Density Lipoproteins and Arterial Walls

2002 ◽  
Vol 40 (1) ◽  
pp. 67-79 ◽  
Author(s):  
Shahida Shafi ◽  
Irina P. Stepanova ◽  
Colin Fitzsimmons ◽  
David E. Bowyer ◽  
Gustav V. R. Born
Keyword(s):  
Low Dose ◽  
High Density ◽  
High Density Lipoproteins ◽  
Dose Treatment ◽  
Arterial Walls

Immunolocalization of high-density lipoproteins in arterial walls of rats

1999 ◽  
Vol 142 (2) ◽  
pp. 269-277 ◽  
Author(s):  
V.C. Yang ◽  
T.Y. Lee ◽  
G.Y. Hwang ◽  
C.H. Kao ◽  
J.K. Chen
Keyword(s):  
High Density ◽  
High Density Lipoproteins ◽  
Arterial Walls

scholarly journals Importance of Apolipoprotein A-I and A-II Composition in HDL and Its Potential for Studying COVID-19 and SARS-CoV-2

Medicines ◽  
2021 ◽  
Vol 8 (7) ◽  
pp. 38
Author(s):  
Kyung-Hyun Cho
Keyword(s):  
Antiviral Activity ◽  
High Density ◽  
High Density Lipoproteins ◽  
Potent Antiviral Activity ◽  
Apolipoprotein A ◽  
Putative Role

The composition and properties of apolipoprotein (apo) A-I and apoA-II in high-density lipoproteins (HDL) might be critical to SARS-CoV-2 infection via SR-BI and antiviral activity against COVID-19. HDL containing native apoA-I showed potent antiviral activity, while HDL containing glycated apoA-I or other apolipoproteins did not. However, there has been no report to elucidate the putative role of apoA-II in the antiviral activity of HDL.

Sign in / Sign up

Export Citation Format

Share Document